Technology
Health
Biotechnology

Allogene Therapeutics

658

$32.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.75 (2.34%) Today
$0.00 (0.00%) As of 4:13 PM EDT after-hours

Why Robinhood?

You can buy or sell ALLO and other stocks, options, ETFs, and crypto commission-free!

About ALLO

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Read More Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam on November 2017 and is headquartered in South San Francisco, CA.

CEO
David D. Chang
Employees
122
Headquarters
South San Francisco, California
Founded
2017
Market Cap
3.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
385.41K
High Today
$32.94
Low Today
$31.57
Open Price
$31.96
Volume
393.11K
52 Week High
$35.55
52 Week Low
$21.67

Collections

Technology
Health
Biotechnology
Cancer Prevention
Therapy
Medical
2018 IPO
US

ALLO Earnings

-$10.71
-$7.23
-$3.74
-$0.26
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 20, Pre-Market
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ALLO

Market Price$32.74
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ALLO stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up